1. Home
  2. YDDL vs CCCC Comparison

YDDL vs CCCC Comparison

Compare YDDL & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDDL

One and One Green Technologies. Inc Class A Ordinary Shares

N/A

Current Price

$5.40

Market Cap

275.4M

ML Signal

N/A

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.23

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDDL
CCCC
Founded
2014
2015
Country
Philippines
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.4M
240.3M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
YDDL
CCCC
Price
$5.40
$2.23
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.25
AVG Volume (30 Days)
65.3K
1.7M
Earning Date
02-23-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
310.92
N/A
EPS
0.15
N/A
Revenue
$62,922,700.00
$30,108,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$35.00
N/A
Revenue Growth
118.15
N/A
52 Week Low
$3.61
$1.09
52 Week High
$8.89
$4.26

Technical Indicators

Market Signals
Indicator
YDDL
CCCC
Relative Strength Index (RSI) N/A 51.48
Support Level N/A $1.87
Resistance Level N/A $2.19
Average True Range (ATR) 0.00 0.13
MACD 0.00 0.01
Stochastic Oscillator 0.00 79.35

Price Performance

Historical Comparison
YDDL
CCCC

About YDDL One and One Green Technologies. Inc Class A Ordinary Shares

One and one Green Technologies Inc is engaged in recycling, production, and trading of recycled scrap metals in the Republic of Philippines. The company process raw materials and generate final products that include copper alloy ingot, aluminum scrapes, plastic beads, and others. It provides economical and flexible solutions to the challenges of electronic waste, metal scrap and industrial recycling. By providing lower-cost alternatives for processing recycled materials, It is not only Contributing to environmental sustainability but also highlight its role as a modern and specialized recycling company.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: